Several studies have indicated that the gut microbiota is a favorable factor associated with the efficacy of ICIs in mouse models and in patients with tumor.15–17,30 Upon CTLA-4 blockade, intraepithelial lymphocytes damage ileal epithelial cells, stimulating the accumulation of Burkholderiales spp. Here, CTLA4 is linked to neoplasm.